UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

The Chameleon Team has a broad range of healthcare communications expertise and experience in virtually every therapeutic category. Our specific experience is propietary to our clients but if you ...

Today, four out of five HCPs say they’re using LLMs to support clinical decision-making. As these LLM models solidify their ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

Creativ-Ceutical is an international consulting firm dedicated to supporting the life science industry and health authorities in strategic decision making.

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets ...

Enterome, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has announced that the US ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...